2026 Q1 Portfolio Activity
In 2026 Q1, Remedium Capital Partners, LLC maintained a portfolio of 6 distinct positions. They heavily accumulated shares in Damora Therapeutics Inc, increasing the position by 1597.9%.
Position History
hover any row below to update
Loading…
Total Positions
6
Quarter
2026 Q1
Top Holding
SYRE (30.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-6 of 6
Remedium Capital Partners, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SYRE
Spyre Therapeut...
|
Healthcare | 30.09% | 28.03% |
#1
Prev: #1
|
8.5 | 451,096 | 31.0% |
P
S
|
1,907,327 | $96,205,574 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
ORKA
Oruka Therapeut...
|
Healthcare | 28.98% | 27.64% |
#2
Prev: #2
|
8.0 | 336,701 | 21.7% |
P
S
|
1,889,115 | $92,661,091 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
GLTO
Damora Therapeu...
|
Healthcare | 16.57% | 1.63% |
#3
3
Prev: #6
|
8.0 | 1,925,000 | 1597.9% |
P
S
|
2,045,473 | $52,977,750 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
APGE
Apogee Therapeu...
|
Healthcare | 15.36% | 25.88% |
#4
1
Prev: #3
|
5.5 | no change | no change |
P
S
|
583,591 | $49,120,854 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
JBIO
Jade Bioscience...
|
Healthcare | 6.93% | 14.30% |
#5
1
Prev: #4
|
4.3 | no change | no change |
P
S
|
1,577,750 | $22,167,388 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
N/A
Crescent Biopha...
|
|
Unknown | 2.08% | 2.52% |
#6
1
Prev: #5
|
1.8 | no change | no change |
P
S
|
361,250 | $6,636,163 | — | 13F Filing | 2026-03-31 | 2026-05-13 |
Showing 1-6 of 6 holdings